arrow
返回
S

Seok Jin Kim

samsung advanced institute of health sciences and technology and sungkyunkwan university

55H指数
694论文数
1.4W被引数
收录论文 180
发表时间
Protocol and Cohort Profile of a Prospective Multicenter Lymphoma Cohort in South Korea韩国前瞻性多中心淋巴瘤队列的研究方案与队列概况
err2026-09-10
err0
PREAI
errDanbee Kang; Kunye Kwak; Ka-Won Kang; Kwai Han Yoo; Yoon Seok Choi; Sang Eun Yoon; Won Seog Kim; Jiyoon Han; Juhee Cho; Seok Jin Kim
err分享
err收藏
Danburstotug, an anti-PD-L1 antibody, in relapsed/refractory extra-nodal natural killer/T-cell lymphoma: The phase 2 DISTINKT study丹努斯妥昔单抗(Danburstotug),一种抗PD-L1抗体,在复发/难治性结外自然杀伤/T细胞淋巴瘤中的应用:DISTINKT二期研究
err2026-09-05
err0
PREAI
errWon Seog Kim; Seok Jin Kim; Jae-Cheol Jo; Sang Eun Yoon; Youngil Koh; Deok-Hwan Yang; Dok Hyun Yoon; Junhun Cho; Sung Young Lee; Suyeon Kim; Seongyeon Kang; Woochan Hwang; Hyukjung Kim; Hwi-yeol Yun; Jihyun Jeon; Chul Ahn; Heung Tae Kim
err分享
err收藏
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01)安巴卡巴基因自体白血病细胞(PD-1和TIGIT敲低CD19 CAR-T)用于复发/难治性大B细胞淋巴瘤(CRC01-01)
errBlood
IF23.1
err2026-06-16
err0
PREAI
errWon Seog Kim; Seok Jin Kim; Dok Hyun Yoon; Hyung Woo Cho; Sang Eun Yoon; Deok Hwan Yang; Ho-jin Shin; Hyeon-Seok Eom; Eunyoung Lee; Ja Min Byun; Young Il Koh; Hyewon Lee; Jongheon Jung; Sung-Soo Yoon; Ga-Young Song; Do Young Kim; Juyeon Hong; Yoon Park; Songhee Han; Su-Hee Cho
err分享
err收藏
Long-term outcomes of 40Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTL
err2026-02-04
err0
errOAAI
errSang Eun Yoon; Dongryul Oh; Gwanghui Ryu; Junhun Cho; Seok Jin Kim; Won Seog Kim
err分享
err收藏
Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B cell lymphoma
err2025-12-11
err0
errOAAI
errSang Eun Yoon; Woorim Kang; Junhun Cho; Hyeon Ji Cho; Mauricio Chalita; Hyun-Seok Oh; Dong-Wook Hyun; Sujeong Han; Hyun Kim; Hojun Sung; Jae-Yun Lee; Bon Park; Kyung Ju Ryu; Hyun-Young Kim; Duck Cho; Won Seog Kim; Seok Jin Kim
err分享
err收藏
Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphomaCD38和PD-1联合抑制(使用isatuximab和cemiplimab)对复发/难治性NK/T细胞淋巴瘤的疗效
errBlood
IF23.1
err2025-03-13
err0
PREAI
errSeok Jin Kim; Jing Quan Lim; Sang Eun Yoon; Deok-Hwan Yang; Ji Hyun Lee; Sung Yong Oh; Yoon Seok Choi; Seong Hyun Jeong; Min Kyoung Kim; Sung Nam Lim; Junhun Cho; Bon Park; Kyung Ju Ryu; Seunghyun Choi; Yoon Park; Kerry May Huifen Lim; Nur Ayuni Binte Muhammad Taib; Choon Kiat Ong; Soon Thye Lim; Won Seog Kim
err分享
err收藏
MiR-340-5p regulates PD-L1 and predicts pembrolizumab response in extranodal NK/T-cell lymphoma
err2025-02-25
err0
errOAAI
errRyu, Kyung Ju; Ji, Haein; Park, Bon; Yoon, Sang Eun; Cho, Junhun; Kim, Won Seog; Kim, Hyeon Ho; Kim, Seok Jin
err分享
err收藏
Exosomal miR-155-5p drives ibrutinib resistance in B-cell lymphoma
err2024-10-01
err0
PREAI
errPark, Bon; Choi, Myung Eun; Ryu, Kyung Ju; Park, Chaehwa; Choi, Minki; Yoon, Sang Eun; Kim, Won Seog; Kim, Hyeon Ho; Hong, Jung Yong; Kim, Seok Jin
err分享
err收藏
Peripheral T-cell lymphoma: From biology to practice to the future
err2024-09-01
err0
PREAI
errO'Connor, Owen A.; Ma, Helen; Chan, Jason Yong Sheng; Kim, Seok Jin; Yoon, Sang Eun; Kim, Won Seog
err分享
err收藏
Clinical Impact of Microbiome Characteristics in Treatment-Naïve Extranodal NK/T-Cell Lymphoma Patients治疗初治性结外NK/T细胞淋巴瘤患者中微生物组特征的临床影响
err2024-08-16
err0
errOAAI
errYoon, Sang Eun; Kang, Woorim; Cho, Junhun; Chalita, Mauricio; Lee, Je Hee; Hyun, Dong-Wook; Kim, Hyun; Kim, Seok Jin; Kim, Won Seog
err分享
err收藏